Chin Lee
Chief Tech/Sci/R&D Officer chez ALLAKOS INC.
Fortune : 417 060 $ au 31/03/2024
Profil
Dr. Chin Lee, MD, is a Chief Medical Officer at Allakos, Inc. Dr. Lee was previously employed as a Chief Medical Officer by Connect Biopharma Holdings Ltd., an Associate Medical Director-Immunoscience Group by Abbott Biotech, Inc., a Global Senior Medical Director-Immunology by Eli Lilly & Co., a Group Medical Director by Genentech, Inc., and a Chief Medical Officer & Head-Clinical Science by Theravance Biopharma, Inc. He received his undergraduate degree from The University of North Carolina at Chapel Hill, a graduate degree from Northwestern University and a doctorate degree from The University of North Carolina at Chapel Hill.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALLAKOS, INC.
0,38% | 16/02/2024 | 331 000 ( 0,38% ) | 417 060 $ | 31/03/2024 |
| 01/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Chin Lee
| Sociétés | Poste | Début |
|---|---|---|
| ALLAKOS INC. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Chin Lee
| Sociétés | Poste | Fin |
|---|---|---|
| Abbott Biotech, Inc. | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - |
| THERAVANCE BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| CONNECT BIOPHARMA HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | - |
Formation de Chin Lee
| Northwestern University | Graduate Degree |
| The University of North Carolina at Chapel Hill | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ALLAKOS INC. | Health Technology |
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| CONNECT BIOPHARMA HOLDINGS LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Abbott Biotech, Inc. |
